所有图片(1/1)
产品介绍 评论(0)
产品规格
宿主来源
Human抗原名称
PD-1分子别名
Programmed cell death protein 1, Protein PD-1, hPD-1, CD279, PDCD1Accession
Q15116克隆号
S-SC016抗体类型
Recombinant mAb抗体同种型
IgG4,k纯化方式
Protein A浓度
2 mg/ml内毒素含量
<1EU/mg标记
Unconjugated性状
Liquid缓冲体系
PBS pH7.4, containing no preservative储存条件
12 months from date of receipt / reconstitution, 2 to 8 °C as supplied
应用
Blocking of PD-1/PD-L signaling Functional assays稀释度
应用 稀释度 ELISA 0.305-5000 ng/ml
背景介绍
Nivolumab is a type of targeted therapy drug called an immune checkpoint inhibitor (a type of immunotherapy). It is a monoclonal antibody that binds to the protein PD-1 on the surface of immune cells called T cells. It works by keeping cancer cells from suppressing the immune system. This allows the immune system to attack and kill the cancer cells.
ELISA
Immobilized human PD-1 at 0.5 μg/ml (50 μL/well) can bind to Nivolumab with a linear range of 0.305 ng/ml-5 μg/ml.

评论(0)